Double blind randomized clinical trial comparing noradrenaline plus placebo versus noradrenaline plus terlipressin in septic shock. - CONTENTSS

Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla0 个研究点目标入组 152 人开始时间: 2024年5月20日最近更新: 2024年7月22日

适应症

试验速览

阶段: 1 期
状态: 进行中（未招募）
发起方: Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla
入组人数: 152

暂无简介。

•Adult patients (18 years or older)., Patients with septic shock., Patients with a SOFA index> 4 points. (If the patient is going to be intubated at the time of randomization, take the neurological SOFA score from the medical record), Signature of the informed consent by the patient or his or her legal representative. (Informed consent may be granted by phone if the legal representative is not present at the center at the time of signing, with written re-consent required as soon as possible)

•Pregnant or lactating patients, Previous use of terlipressin during your stay in the ICU, Previous use of vasopressin., Known allergy to terlipressin, Pathologies on which terlipressin is clinically indicated: gastrointestinal bleeding due to esophageal-gastric varices, hepatorenal syndrome., Patients diagnosed with unstable acute coronary syndrome., Patients with acute or chronic mesenteric ischemia, Patients with Raynaud's Phenomenon, or vasospastic disease., Patients participating in another intervention clinical trial., Patients with active bleeding., Patients with renal replacement technique at the time of randomization., Patients with some limitation of life support treatment (LLST).

发起方